These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 35244668

  • 1. Modifications, biological origin and antibacterial activity of naphthalenoid ansamycins.
    Skrzypczak N, Przybylski P.
    Nat Prod Rep; 2022 Sep 21; 39(9):1653-1677. PubMed ID: 35244668
    [Abstract] [Full Text] [Related]

  • 2. Structural diversity and biological relevance of benzenoid and atypical ansamycins and their congeners.
    Skrzypczak N, Przybylski P.
    Nat Prod Rep; 2022 Sep 21; 39(9):1678-1704. PubMed ID: 35262153
    [Abstract] [Full Text] [Related]

  • 3. Specific Interactions between Rifamycin Antibiotics and Water Influencing Ability To Overcome Natural Cell Barriers and the Range of Antibacterial Potency.
    Pyta K, Janas A, Skrzypczak N, Schilf W, Wicher B, Gdaniec M, Bartl F, Przybylski P.
    ACS Infect Dis; 2019 Oct 11; 5(10):1754-1763. PubMed ID: 31461259
    [Abstract] [Full Text] [Related]

  • 4. Synthetic ansamycins prepared by a ring-expanding Claisen rearrangement. Synthesis and biological evaluation of ring and conformational analogues of the Hsp90 molecular chaperone inhibitor geldanamycin.
    McErlean CS, Proisy N, Davis CJ, Boland NA, Sharp SY, Boxall K, Slawin AM, Workman P, Moody CJ.
    Org Biomol Chem; 2007 Feb 07; 5(3):531-46. PubMed ID: 17252137
    [Abstract] [Full Text] [Related]

  • 5. Natural occurrence, bioactivity, and biosynthesis of triene-ansamycins.
    Yang X, Wu W, Li H, Zhang M, Chu Z, Wang X, Sun P.
    Eur J Med Chem; 2022 Dec 15; 244():114815. PubMed ID: 36240545
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory activity of ansamycins.
    Labro MT.
    Expert Rev Anti Infect Ther; 2005 Feb 15; 3(1):91-103. PubMed ID: 15757460
    [Abstract] [Full Text] [Related]

  • 12. Structure-activity relationships in the ansamycins. Molecular structure and activity of 3-carbomethoxy rifamycin S.
    Brufani M, Cellai L, Cerrini S, Fedeli W, Segre A, Vaciago A.
    Mol Pharmacol; 1982 Mar 15; 21(2):394-9. PubMed ID: 7048060
    [Abstract] [Full Text] [Related]

  • 13. A mechanistic and structural analysis of the inhibition of the 90-kDa heat shock protein by the benzoquinone and hydroquinone ansamycins.
    Reigan P, Siegel D, Guo W, Ross D.
    Mol Pharmacol; 2011 May 15; 79(5):823-32. PubMed ID: 21285336
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. 3-Hydroxyrifamycin S and further novel ansamycins from a recombinant strain R-21 of Nocardia mediterranei.
    Traxler P, Schupp T, Fuhrer H, Richter WJ.
    J Antibiot (Tokyo); 1981 Aug 15; 34(8):971-9. PubMed ID: 7319930
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chemical modifications of the aliphatic bridge of ansamycins. 2. Synthesis and activity of 23-epi-25-deacetylrifamycin S.
    Brufani M, Cecchini G, Cellai L, Federici M, Guiso M, Segre A.
    J Antibiot (Tokyo); 1985 Feb 15; 38(2):259-62. PubMed ID: 3997671
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.